Precipio

$2.72
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.

+$0.06 (+2.26%) Today
$0.00 (0.00%) As of 11:01 PM UTC after-hours

Why Robinhood?

You can buy or sell Precipio and other stocks, options, and ETFs commission-free!

About PRPO

Precipio, Inc. Common Stock, also called Precipio, is a cancer diagnostics company, which engages in the development and provision of a platform designed to eradicate the problem of misdiagnosis. Its products include MX-ICP, HemeScreen, and IV-Cell, and services include primary diagnostic, SmartPath, SmartGen, HRM kits and ICP liquid biopsy testing. The company was founded on March 6, 1997 and is headquartered in New Haven, CT. The listed name for PRPO is Precipio, Inc. Common Stock.

CEO
Ilan Danieli
Employees
51
Headquarters
New Haven, Connecticut
Founded
1997
Market Cap
47.61M
Price-Earnings Ratio
—
Dividend Yield
—
Average Volume
1.28M
High Today
$2.82
Low Today
$2.66
Open Price
$2.67
Volume
262.25K
52 Week High
$8.00
52 Week Low
$0.55

PRPO Earnings

-$0.78
-$0.52
-$0.26
$0.00
Q2 FY19
Q3 FY19
Q4 FY19
Q1 FY20
Q2 FY20
Q3 FY20
Q4 FY20
Estimated
— per share
Actual
Expected Apr 6, After Hours

You May Also Like

PRGX
All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, a registered broker-dealer and Member SIPC. Full disclosure